US Drug Recall Register
Class I · High risk Terminated Initiated Apr 18, 2020 (6 years ago)

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

What was recalled

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

Recalling firm
B. Braun Medical Inc
NDC code
0264-3145-11
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1257-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ceftazidime recalls

See all